Current Strategies of Cancer Chemoprevention: 13th Sapporo Cancer Seminar

Cancer Research

Volumn 54, Issue 12, 1986, Pages 3315-3318

  Wattenberg, Lee W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; ARACHIDONIC ACID; BETA CAROTENE; BISMUTH NITRATE; CAROTENOID; COUMARIN DERIVATIVE; EPIGALLOCATECHIN; FENRETINIDE; INDOMETACIN; ISOTRETINOIN; KRESTIN; LIMONENE; LINAZOLAST; LIPOXYGENASE; LIPOXYGENASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; PIROXICAM; POLYPRENOIC ACID; PROSTAGLANDIN SYNTHASE; PYRIDINE DERIVATIVE; RETINOIC ACID; RETINOL; SARCOPHYTOL A; SELENOMETHIONINE; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER PREVENTION; CANCER RECURRENCE; CARCINOGENESIS; CHEILITIS; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRY SKIN; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; HYPEROSTOSIS; IN SITU HYBRIDIZATION; LIVER CANCER; LUNG CANCER; MELANOMA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEA; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION;

ANTICARCINOGENIC AGENTS; CLINICAL TRIALS; HUMANS; NEOPLASMS;

EID: 0028340482     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wattenberg, L., Lipkin, M., Boone, C. W., and Kelloff, G. J. (eds.). Cancer Chemoprevention. Boca Raton, FL: CRC Press, Inc., 1992.
2. Wattenberg, L. W. Prevention—therapy—basic science and the resolution of the cancer problem: presidential address. Cancer Res., 53: 5890–5896, 1993.
3. Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, F., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cw-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501–1505, 1986.
4. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795–801, 1990.
5. Thun, M. J., Namboodiri, M. M., and Health, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
6. Kune, G. A., Kune, S., and Watson, L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48: 4399–4404, 1988.
7. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of the large-bowel cancer. J. Natl. Cancer Inst., 83: 355–358, 1991.
8. Wattenberg, L. W., Lam, L. K., Fladmoe, A. V. Inhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelicalactone. Cancer Res., 39: 1651–1654, 1979.
9. Zanker, K. S. In: S. Salmon (ed.), Adjuvant Therapy of Cancer VII. New York: J. B. Lippincott Co., 1993.
10. Boone, C. W., Kelloff, G. J., and Freedman, L. S. Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive action. J. Cell. Biochem., Suppl. 17G: 14-25,1993.
11. Selby, J. V., Friedman, G. D., Quesenberry, C. P. J., and Weiss, N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med., 326: 653–657, 1993.
12. Huang, M-T., Ho, C. T., Wang, Z. Y., Ferraro, T., Finnegan-Olive, T., Lou, Y. R., Mitchell, J. M., Laskin, J. D., Newmark, H., Yang, C. S., and Conney, A. H. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis (Lond.) 13: 947–954, 1992.
13. Yoshizawa, S., Horiuchi, T., Suganuma, M., Nishiwaki, S., Yatsunami, J., Okabe, S., Okuda, T., Muto, Y., Frenkel, K., Troll, W., and Fujiki, H. Penta-O-galloyl-β-D-glucose and (-)-epigallocatechin gallate: cancer prevention agent. In: M-T. Huang, C-T. Ho, and C. Y. Lee (eds.), Phenolic Compounds in Foods and Health II: Antioxidants and Cancer Prevention, pp. 316–325. Washington, DC: American Chemical Society, 1992.
14. Yang, C. S., Hong, J-Y., and Wang, Z-Y. Inhibition of nitrosamine-induced tumorigenesis by diallyl sulfide and tea. In: K. Waldron (ed.), Food and Cancer Prevention ’92, pp. 247–252. Cambridge, United Kingdom: Royal Society of Chemistry, 1993.
15. Wang, Z-Y., Huang, M. T., Ferraro, T., Wong, C. Q., Lou, Y. R., Reuhl, K., Iatropoulos, M., Yang, C. S., and Conney, A. H. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res., 52: 6657–6665, 1992.
16. Khan, S. G., Katiyar, S. K., Agarwal, R., and Mukhtar, H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res., 52: 4050–4052, 1992.
17. Kobayashi, H., Matsunaga, K., and Fujii, M. PSK as a chemopreventive agent. Cancer Epidemiol. Biomark. Prev., 2: 271–276, 1993.
18. Wargovich, M. J., Harris, C., Chen, D. D., Palmer, C., Steele, V. E., and Kelloff, G. J. Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell. Biochem. Suppl., 16G: 51–54, 1992.